CClinicalTrials.gg
CompletedNCT04500457Updated Jul 27, 2023Results posted

Exposure-Based Treatment for Perfectionism

An interventional study of Exposure-based Treatment for Perfectionism (ETP) in Perfectionism, sponsored by Florida State University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-07-27.

Sponsored by Florida State University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Oct 2019, registered Aug 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study is examining the efficacy of a computerized, exposure-based, intervention for perfectionism.

Read the detailed description

The primary aim of this study is to evaluate the effects of a two-week computerized exposure-based treatment for perfectionism (ETP). Individuals with elevated perfectionism will be randomly assigned to ETP or a waitlist (WL) control condition. ETP will consist of three tasks in which they will repeatedly make mistakes, repeated for five sessions over a two-week period (one session every 3 days).

02

Conditions studied

  • Perfectionism
03

In context

Lead sponsor

Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Score of at least 29 on the Frost Multidimensional Perfectionism Scale- Concern over Mistakes subscale

Exclusion criteria

Exclusion Criteria:

  • Current moderate or severe substance use disorder, psychotic disorder, or bipolar disorder
  • Current suicidal ideation (imminent risk)
  • Currently participating in psychotherapy
  • Any changes to psychotropic medications in the past four weeks
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
76 participants (actual)

Study arms

  • Experimental
    Intervention

    This arm consists of a 2-week computerized, exposure-based intervention. Treatment sessions are completed every 3 days at home (5 treatment sessions total).

    Behavioral: Exposure-based Treatment for Perfectionism (ETP)

  • No intervention
    Wait-List Control

    Participants in this condition will not receive treatment.

Interventions

  • BehavioralExposure-based Treatment for Perfectionism (ETP)

    Three tasks focused on exposures are completed. Each treatment session is approximately twenty minutes.

06

What researchers measure

Primary outcomes

  1. Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale

    Self-report questionnaire examining levels of perfectionism. The concern over mistakes sub-scale of the Frost Multidimensional Perfectionism Scale includes 9 items with scores on the sub-scale ranging from 9 to 45 (higher scores signify higher levels of concern over mistakes). The concern over mistakes sub-scale includes the following items from the Frost Multidimensional Perfectionism Scale: 9, 10, 13, 14, 18, 21, 23, 25, 24. Item scores are summed for a total sub-scale score.

    Time frame: Levels of perfectionism from baseline to post treatment (2 weeks)

Secondary outcomes

  1. Center for Epidemiological Studies Depression Scale (CES-D)

    Self-report measure used to assess depressive symptoms. Total scores range from 0 to 60 with higher scores indicating a higher level of depressive symptoms.

    Time frame: Depression symptoms from baseline to post treatment (2 weeks)

  2. State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)

    Self-report measure used to assess overall anxiety symptoms. Scores range from 21 to 84 with higher scores indicating higher levels of overall anxiety.

    Time frame: Anxiety symptoms from baseline to post treatment (2 weeks)

  3. Social Phobia Inventory (SPIN)

    Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

    Time frame: Social anxiety symptoms from baseline to post treatment (2 weeks)

  4. Eating Attitudes Test (EAT-26)

    Self-report scale that measures eating disorder symptoms. Scores range from 0 to 78 with higher scores indicating higher levels of eating disorder symptoms.

    Time frame: Eating disorder symptoms from baseline to post treatment (2 weeks)

  5. Obsessive-Compulsive Inventory- Revised (OCI-R)

    Self-report scale that measures obsessive-compulsiveness. Scores range from 0 to 72 with higher scores indicating higher levels of obsessive-compulsiveness.

    Time frame: Obsessive-compulsiveness from baseline to post treatment (2 weeks)

07

Results

Posted Jul 27, 2023

Participant flow

Participant flow — Overall Study
MilestoneInterventionWait-List Control
Started3937
Completed3635
Not completed32

Outcome measures

PrimaryFrost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale

Self-report questionnaire examining levels of perfectionism. The concern over mistakes sub-scale of the Frost Multidimensional Perfectionism Scale includes 9 items with scores on the sub-scale ranging from 9 to 45 (higher scores signify higher levels of concern over mistakes). The concern over mistakes sub-scale includes the following items from the Frost Multidimensional Perfectionism Scale: 9, 10, 13, 14, 18, 21, 23, 25, 24. Item scores are summed for a total sub-scale score.

Time frame:
Levels of perfectionism from baseline to post treatment (2 weeks)
Reported as:
Mean · units on a scale
Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale
units on a scaleInterventionWait-List Control
Baseline36.54 ± 4.1035.76 ± 4.06
Post-test30.97 ± 6.3935.71 ± 4.16
SecondaryCenter for Epidemiological Studies Depression Scale (CES-D)

Self-report measure used to assess depressive symptoms. Total scores range from 0 to 60 with higher scores indicating a higher level of depressive symptoms.

Time frame:
Depression symptoms from baseline to post treatment (2 weeks)
Reported as:
Mean · units on a scale
Center for Epidemiological Studies Depression Scale (CES-D)
units on a scaleInterventionWait-List Control
Baseline19.26 ± 8.3322.97 ± 12.75
Post-test14.69 ± 8.1223.77 ± 11.47
SecondaryState-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)

Self-report measure used to assess overall anxiety symptoms. Scores range from 21 to 84 with higher scores indicating higher levels of overall anxiety.

Time frame:
Anxiety symptoms from baseline to post treatment (2 weeks)
Reported as:
Mean · units on a scale
State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)
units on a scaleInterventionWait-List Control
Baseline41.33 ± 9.7543.95 ± 12.90
Post-test39.19 ± 11.0743.95 ± 11.10
SecondarySocial Phobia Inventory (SPIN)

Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

Time frame:
Social anxiety symptoms from baseline to post treatment (2 weeks)
Reported as:
Mean · units on a scale
Social Phobia Inventory (SPIN)
units on a scaleInterventionWait-List Control
Baseline29.15 ± 13.0830.08 ± 17.12
Post-test26.58 ± 12.7932.31 ± 16.36
SecondaryEating Attitudes Test (EAT-26)

Self-report scale that measures eating disorder symptoms. Scores range from 0 to 78 with higher scores indicating higher levels of eating disorder symptoms.

Time frame:
Eating disorder symptoms from baseline to post treatment (2 weeks)
Reported as:
Mean · units on a scale
Eating Attitudes Test (EAT-26)
units on a scaleInterventionWait-List Control
Baseline13.82 ± 9.0912.03 ± 9.63
Post-test12.05 ± 9.4614.34 ± 11.18
SecondaryObsessive-Compulsive Inventory- Revised (OCI-R)

Self-report scale that measures obsessive-compulsiveness. Scores range from 0 to 72 with higher scores indicating higher levels of obsessive-compulsiveness.

Time frame:
Obsessive-compulsiveness from baseline to post treatment (2 weeks)
Reported as:
Mean · units on a scale
Obsessive-Compulsive Inventory- Revised (OCI-R)
units on a scaleInterventionWait-List Control
Baseline22.89 ± 13.1826.68 ± 13.67
Post-test21.34 ± 13.9525.54 ± 13.24

Adverse events

Collected over Baseline up to 2 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/39 (0%)0/39 (0%)0/39 (0%)
Wait-List Control0/37 (0%)0/37 (0%)0/37 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)InterventionWait-List ControlTotal
Mean20.10 ± 6.0918.89 ± 1.3119.91 ± 4.47
Sex: Female, Male
Sex: Female, Male(Participants)InterventionWait-List ControlTotal
Female373572
Male224
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)InterventionWait-List ControlTotal
Black404
White272653
Hispanic41014
Asian or Pacific Islander314
Other101
Region of Enrollment
Region of Enrollment(participants)InterventionWait-List ControlTotal
United States393776
08

Study locations

1 site
  • Florida State University, Department of Psychology
    Tallahassee, Florida 32306, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 28, 2020

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04500457
Lead sponsor
Florida State University
Responsible party
Jesse Cougle (Associate Professor of Psychology, Florida State University) — Principal investigator
First posted
Aug 5, 2020
Start date
Oct 3, 2019
Primary completion
Feb 26, 2021
Completion
Feb 26, 2021
Results posted
Jul 27, 2023
Last update
Jul 27, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion